Phenogen Sciences, a subsidiary of Genetic Technologies, has unveiled a non-invasive genetic risk assessment test for women with estrogen-receptor positive breast cancer. The BREVAGen uses patients oral-swab samples to calculate patient's ...
Tags: non-invasive genetic risk assessment test, cancer test